重复暴露于网胶敷料与过敏性接触性皮炎相关:一项前瞻性队列研究
该前瞻性队列研究在单中心纳入2023年8月至2024年5月间222例患者的245次关节置换手术,比较既往暴露与未暴露于网胶敷料者过敏性接触性皮炎(ACD)的发生率。结果显示暴露组ACD发生率为8.1%(7/86),未暴露组为1.9%(3/159),P=0.030;校正混杂因素后暴露组发生ACD的比值比为6.48(95%CI 1.64-25.43,P=0.003)。作者认为既往暴露使ACD风险增加约6倍,可能为IV型迟发型超敏反应。
要点
- 既往暴露于网胶敷料者ACD发生率为8.1%(7/86),未暴露者为1.9%(3/159),P=0.030。
- 校正性别、年龄、BMI、手术类型和Charlson合并症指数后,暴露组发生ACD的OR为6.48(95%CI 1.64-25.43,P=0.003)。
- 作者认为既往暴露使ACD风险增加约6倍,可能通过IV型迟发型超敏反应介导。
核心结论
- 既往暴露于网胶敷料使ACD风险较未暴露患者增加约6倍,可能通过IV型迟发型超敏反应介导。
- 虽然症状经治疗均消退,但鉴于ACD风险,临床医生应权衡重复使用该敷料的获益。
研究设计与样本
- 前瞻性队列研究,单中心,2023年8月至2024年5月纳入222例患者的245次手术(163次全膝关节置换、69次全髋关节置换、13次单间室膝关节置换)。
- 按既往是否暴露于所研究的网胶敷料分为暴露组(86次手术)和未暴露组(159次手术),排除既往对该敷料有皮肤反应或暴露情况不明者。
- 术后第7天和第14天进行皮肤检查,主要结局为需要治疗的ACD,采用多因素logistic回归分析敷料暴露对ACD的独立风险。
主要发现
- 暴露组ACD发生率为8.1%(7/86),未暴露组为1.9%(3/159),P=0.030。
- 两组年龄、性别、吸烟状态、体重指数和Charlson合并症指数无差异(P > 0.05)。
- 校正性别、年龄、体重指数、手术类型和Charlson合并症指数后,暴露组发生ACD的OR为6.48(95%CI 1.64-25.43,P=0.003)。
关键数值与推荐
- 暴露组ACD 7/86(8.1%)vs 未暴露组3/159(1.9%),P=0.030。
- 校正后暴露组发生ACD的OR为6.48(95%CI 1.64-25.43,P=0.003)。
- 证据等级:治疗性II级。
临床怎么用
- 作者认为,鉴于重复使用该敷料存在ACD风险,临床医生应权衡其获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Certain postoperative dressing types have been associated with allergic contact dermatitis (ACD), presenting as a peri-incisional eczematous skin reaction. The purpose of this study was to compare rates of ACD following arthroplasty between patients who have prior exposure and those naïve to a specific dressing type (self-adhesive polyester mesh and 2-octyl cyanoacrylate liquid adhesive). METHODS: There were 222 patients undergoing 245 procedures (163 total knee arthroplasties, 69 total hip arthroplasties, and 13 unicompartmental knee arthroplasties) who were prospectively evaluated between August 2023 and May 2024 at a single institution. Patients were categorized as "exposed" or "naïve" based on prior exposure to the studied dressing. Patients were excluded if they had a previous skin reaction to the mesh-glue dressing or unknown exposure. Skin checks were performed on postoperative days 7 and 14. The primary outcome of the study was ACD requiring treatment. Baseline demographics, comorbidities, and 90-day complications were compared. Multivariable logistic regression analysis was utilized to determine the independent risk of dressing exposure on ACD. There were 86 procedures in patients previously exposed and 159 in those naïve to a specific dressing type. There were no differences in age, sex, smoking status, body mass index, or Charlson Comorbidity Index between the two cohorts (P > 0.05). RESULTS: An ACD was more common in exposed patients (seven of 86; 8.1%) than in naïve patients (three of 159; 1.9%; P = 0.030). After controlling for sex, age, body mass index, procedure type, and Charlson Comorbidity Index, exposed patients were more likely to experience ACD (odds ratio: 6.48, 95% confidence interval: 1.64 to 25.43, P = 0.003). CONCLUSIONS: Previous exposure to the mesh-glue dressing increases the risk of ACD by 6-fold as compared to dressing naïve patients. This is likely through a type-IV delayed hypersensitivity reaction. Although symptoms uniformly resolved with treatment, clinicians should weigh the benefits of repeat use of this dressing given the risk of ACD. LEVEL OF EVIDENCE: Therapeutic Level II.
引用
- Jones CM, Burnett RA, Atkins MA, et al. Repeat Exposure to Mesh-Glue Dressing Is Associated With Allergic Contact Dermatitis: A Prospective Cohort Study. J Arthroplasty. 2025. PMID: 40349859. doi:10.1016/j.arth.2025.05.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。